Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lisinopril and valsartan for vascular remodeling in children with idiopathic nephrotic syndrome
TCTR20260923002Phase 2Completed
- Sponsor
- N/A
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lisinopril, valsartan in Idiopathic nephrotic syndrome (INS), chronic kidney disease (CKD), sponsored by N/A. Started Jun 2024; status: completed.
02
Drugs
lisinoprilvalsartan
03
Conditions
Idiopathic nephrotic syndrome (INS)chronic kidney disease (CKD)
Beyond the preview
Go deeper on TCTR20260923002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260923002.